1. Anticoagulation Therapy in Patients Post-TAVR

4. Use of TAVR Is Expanding

5. DAPT in TAVR

6. STARS

7. DAPT in TAVR

8. Management During and After TAVR

9. Post-TAVR

10. Post-TAVR Anticoagulation

11. Rationale for Anticoagulation

12. BRAVO-3

13. Current ACC/AHA, ACCP, and ESC Guideline Recommendations for Antithrombotic Therapy Within 3 mo After Bioprosthetic Valve Replacement

14. ATLANTIS Trial Design Apixaban in Patients Who Underwent a Clinically Successful TAVI Procedure

15. GALILEO Trial Design

16. Summary

17. Summary (cont)

18. Abbreviations

19. Abbreviations (cont)